Lucid Diagnostics Inc. - Common Stock (NQ:LUCD)

0.9617 -0.0083 (-0.86%)

Streaming Delayed Price Updated: 9:45 AM EDT, Aug 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lucid Diagnostics Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 24, 2022

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...

Via Benzinga

PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study

March 24, 2022

From Lucid Diagnostics Inc.

Via Business Wire

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

March 23, 2022

From Lucid Diagnostics Inc.

Via Business Wire

PAVmed Appoints Shaun O’Neil as Chief Operating Officer

February 24, 2022

From PAVmed Inc.

Via Business Wire

Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors

February 15, 2022

From PAVmed Inc.

Via Business Wire

Analyst Ratings For Lucid Diagnostics ↗

December 27, 2021

Lucid Diagnostics (NASDAQ:LUCD) has observed the following analyst ratings ...

Via Benzinga

Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference

February 10, 2022

From Lucid Diagnostics Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 02, 2022

Gainers Syros Pharmaceuticals (NASDAQ:SYRS

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 19, 2022

Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 19, 2022

Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

20 Stocks Moving in Wednesday's Pre-Market Session ↗

January 19, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company. Fresh Vine Wine, Inc. (NYSE: VINE) rose...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 14, 2022

Gainers Avinger (NASDAQ:AVGR) stock moved...

Via Benzinga

PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team

January 12, 2022

From PAVmed Inc. and Lucid Diagnostics Inc.

Via Business Wire

10 Low-Float Penny Stocks for Steel-Gutted Investors ↗

January 11, 2022

If you’re willing to absorb massive risk for the chance of significant upside, these low-float penny stocks could fit the bill.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 10, 2022

Gainers Inari Medical (NASDAQ:NARI) stock...

Via Benzinga

Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference

January 06, 2022

From Lucid Diagnostics Inc.

Via Business Wire

34 Stocks Moving In Monday's Mid-Day Session ↗

December 27, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY...

Via Benzinga

51 Biggest Movers From Yesterday ↗

December 28, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 27, 2021

Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 55.35% to $8.42 during Monday's pre-market session. The company's market cap stands at $59.8 million...

Via Benzinga

PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth

December 01, 2021

From Lucid Diagnostics Inc.

Via Business Wire

61 Biggest Movers From Yesterday ↗

November 18, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped...

Via Benzinga

Topics Initial Public Offering

42 Stocks Moving In Wednesday's Mid-Day Session ↗

November 17, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed...

Via Benzinga

Topics Initial Public Offering

Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

November 17, 2021

From Lucid Diagnostics Inc. PAVmed Inc.

Via Business Wire

PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results

November 16, 2021

From PAVmed Inc. and Lucid Diagnostics Inc.

Via Business Wire

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

November 11, 2021

From Lucid Diagnostics Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 ↗

November 08, 2021

Upgrades For Nektar Therapeutics (NASDAQ:

Via Benzinga

PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021

November 03, 2021

From PAVmed Inc. and Lucid Diagnostics Inc.

Via Business Wire

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award

October 28, 2021

From Lucid Diagnostics Inc.

Via Business Wire

ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer

October 21, 2021

From Lucid Diagnostics Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.